GlaxoSmithKline Intellectual Property (No. 2) Ltd., a subsidiary of GSK Plc, is a company headquartered in Brentford, UK, that provides business support services. The firm was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies and carrying out research and development activities.

Kao Corp. engages in the manufacture and sale of consumer and chemical products. It operates through the following segments: Consumer Products, Chemical, and Others. The Consumer Products segment includes Cosmetics, Skin Care and Hair Care, Human Health Care, Fabric and Home Care Businesses. The Cosmetics business offers make-up products such as RMK, SUQQU, Primavista, COFFRET DOR, KATE, SENSAI, and Molton Brown. The Skin Care and Hair Care business delivers skin care products such as facial cleansers, body cleansers, sunscreens, and body lotions. It also includes hair care products such as shampoos, conditioners, and hair colors. The Human Health Care business provides sanitary products such as Laurier sanitary napkins, Merries baby diapers, Relief adult diapers, Healthya functional beverage, Clear Clean, and Deep Clean toothpastes. The Fabric and Home Care business includes Attack and Newbeads laundry detergent, Humming and Flair Fragrance fabric softener, CuCute dishwashing detergent, and Magiclean household cleaners. The Chemical segment offers oleochemicals made from natural fat and oil, performance chemicals such as surfactants, and specialty chemicals such as toners and toner binders. The Others segment handles expansion and maintenance of logistics facilities and information technology (IT)-related investments. The company was founded by Tomiro Nagase on June 19, 1887 and is headquartered in Tokyo, Japan.

RaQualia began operations in July 2008 with a corporate mission, "They seek to bring people health and happiness through innovative new medications." Thanks to the support of all of their stakeholders, the company was listed on the JASDAQ Growth Market in July 2011. They have transformed RaQualia's R&D strategy, which is now based on the concept of "selection and concentration." They are now focusing on their core competencies in targeting ion channels in the fields of pain and gastrointestinal disease. In addition, they have made a strategic decision to relocate RaQualia's discovery processes to Nagoya University to better promote synergy effects with academia. With the Chubu region as their base, they are continuing with further efforts enhance their capabilities in drug discovery, improve shareholder value, and achieve financial stability by promoting licensing activities and alliance management with their corporate partners. They will continue to work tirelessly in providing patients with innovative medicines sooner by increasing the pace of drug development. Thank you very much for your continued support of RaQualia.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

TOYO SHINYAKU Co., Ltd. engages in the consigned manufacture and sale of health food products, medicines, cosmetics, ingredients for quasi drugs and foshu products. The company was founded on March 19, 1993 and is headquartered in Fukuoka, Japan.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Green Zen Biotechnology (Hangzhou) Co., Ltd., established on 2018-05-08, The scope of business includes the field of ecological agricultural science and technology(In addition to the rare and unique precious varieties in my country and the breeding of new varieties of crops and seed production)technology development,technical consulting,Technical Services,Achievement transfer;technology development,technical consulting,Technical Services,Achievement transfer:IoT technology,sensor,data processing technology,computer system integration,medical technology,LEDLighting Equipment and Accessories,Air purification equipment and accessories,Water purification equipment and accessories,Biotechnology;wholesale,Retail and Import and Export:Primary Edible Agricultural Products(except food,medicine),spices,essential oil,LEDLighting Equipment and Accessories,Air purification equipment and accessories,Water purification equipment and accessories,feed,Nutrient solution,Pre-packaged food,bulk food,special food(Healthy food,Sales of formula food for special medical purposes),Daily necessities,cosmetic(Repacking)(Except those involving the implementation of special access management measures stipulated by the state)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

The Kobayashi Pharmaceutical Group provides a variety of products in fields such as pharmaceuticals, fragrances, dietary supplements and daily necessities. Providing products in these diverse fields is a business activity based on the broader management philosophy of “Providing Great Pleasure to People and Society” regardless of the current business domain. The current management philosophy was newly created in April 1999 by adding the meanings of “creation and innovation” and “Something New Something Different”, which are one of the characteristics of the Kobayashi Pharmaceutical Group, to the conventional management philosophy. is. The Kobayashi Pharmaceutical Group believes that pursuing the provision of “Pleasure” for people and society in this management philosophy is the significance of the Kobayashi Pharmaceutical Group.

Mandom Corp. engages in the manufacture and sale of cosmetics, fragrance products and quasi-drugs. Its operations are carried out through the following business divisions: Cosmetics and Others. The Cosmetics division provides make-up kits, skin care, body care, hair care, hair colouring, daily grooming, and hair styling products for men and women. The Others division includes insurance agency business and building management services. The company was founded on December 23, 1927 and is headquartered in Osaka, Japan.

Fujimoto Holdings Co., Ltd. is a Japanese private company located in Tokyo with a presence in China, Taiwan and Japan that operates a holding company with interests in healthcare product production and distribution.

Shiseido Co., Ltd. engages in the production and sale of cosmetics for men and women. It operates through the following segments: Japan, China, Asia Pacific, Americas, Europe, Travel Retail, Professional, and Others. The Japan, China, Asia Pacific, Americas, and Europe segments sell cosmetics, fragrance, and personal care products with core brands such as Shiseido, clé de peau BEAUTÉ, ELIXIR, MAQUILLAGE, AUPRES, urara, TSUBAKI, Za, and narciso rodriguez in each corresponding region. The Travel Retail segment retails Shiseido, clé de peau BEAUTÉ, bareMinerals, and NARS brands in airport duty-free shops excluding Japan. The Professional segment manages the sale of beauty products in Japan, China, and Asia. The Others segment includes headquarter functions, production, frontier science, and restaurant businesses. The company was founded by Arinobu Fukuhara on September 17, 1872 and is headquartered in Tokyo, Japan.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.